Isdin Oke, Efren Gonzalez, Tobias Elze, Joan W. Miller, Alice C. Lorch, David G. Hunter, Jennifer M. Yeh, Lisa R. Diller, Ann Chen Wu
{"title":"IRIS® 注册表中视网膜母细胞瘤幸存者的视力与种族、民族和保险状况的关系","authors":"Isdin Oke, Efren Gonzalez, Tobias Elze, Joan W. Miller, Alice C. Lorch, David G. Hunter, Jennifer M. Yeh, Lisa R. Diller, Ann Chen Wu","doi":"10.1080/09286586.2024.2315075","DOIUrl":null,"url":null,"abstract":"To identify sociodemographic factors associated with the visual outcomes of retinoblastoma survivors.Retrospective cohort study using a US-based clinical data registry. All individuals < 18 years o...","PeriodicalId":19607,"journal":{"name":"Ophthalmic epidemiology","volume":null,"pages":null},"PeriodicalIF":1.7000,"publicationDate":"2024-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Association of Race, Ethnicity, and Insurance Status with the Visual Acuity of Retinoblastoma Survivors in the IRIS® Registry\",\"authors\":\"Isdin Oke, Efren Gonzalez, Tobias Elze, Joan W. Miller, Alice C. Lorch, David G. Hunter, Jennifer M. Yeh, Lisa R. Diller, Ann Chen Wu\",\"doi\":\"10.1080/09286586.2024.2315075\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"To identify sociodemographic factors associated with the visual outcomes of retinoblastoma survivors.Retrospective cohort study using a US-based clinical data registry. All individuals < 18 years o...\",\"PeriodicalId\":19607,\"journal\":{\"name\":\"Ophthalmic epidemiology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2024-04-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ophthalmic epidemiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/09286586.2024.2315075\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmic epidemiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/09286586.2024.2315075","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
The Association of Race, Ethnicity, and Insurance Status with the Visual Acuity of Retinoblastoma Survivors in the IRIS® Registry
To identify sociodemographic factors associated with the visual outcomes of retinoblastoma survivors.Retrospective cohort study using a US-based clinical data registry. All individuals < 18 years o...
期刊介绍：
Ophthalmic Epidemiology is dedicated to the publication of original research into eye and vision health in the fields of epidemiology, public health and the prevention of blindness. Ophthalmic Epidemiology publishes editorials, original research reports, systematic reviews and meta-analysis articles, brief communications and letters to the editor on all subjects related to ophthalmic epidemiology. A broad range of topics is suitable, such as: evaluating the risk of ocular diseases, general and specific study designs, screening program implementation and evaluation, eye health care access, delivery and outcomes, therapeutic efficacy or effectiveness, disease prognosis and quality of life, cost-benefit analysis, biostatistical theory and risk factor analysis. We are looking to expand our engagement with reports of international interest, including those regarding problems affecting developing countries, although reports from all over the world potentially are suitable. Clinical case reports, small case series (not enough for a cohort analysis) articles and animal research reports are not appropriate for this journal.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
